No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Bone Marrow / physiology
-
Combined Modality Therapy
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Multiple Myeloma* / diagnosis
-
Multiple Myeloma* / genetics
-
Multiple Myeloma* / physiopathology
-
Multiple Myeloma* / therapy
-
Neoplasm Staging
-
Plasma Cells / physiology
-
Remission Induction
-
Stem Cell Transplantation*
-
Translocation, Genetic
-
Transplantation Conditioning
-
Watchful Waiting
Substances
-
Antineoplastic Agents
-
Immunosuppressive Agents